Nabota’s Partner Evolus Raises 2023 Sales Forecast to $195 Million
Nabota’s Partner Evolus Raises Sales Forecast to $195 Million in Q2 2023 In a recent announcement, Daewoong Pharmaceutical’s CEOs Jeon Seung-ho and Lee Chang-jae revealed that Evolus, a partner of Nabota, has released its second-quarter results for 2023. The company’s sales forecast has been raised to $195 million (approximately KRW 250 billion) after a strong […]
Daewoong Pharmaceutical Achieves Highest Sales and Profits in Q2, Driven by Innovative New Drugs
Daewoong Pharmaceutical Reports Record-High Sales and Operating Profit in Q2 Daewoong Pharmaceutical, led by CEOs Jeon Seung-ho and Lee Chang-jae, has achieved remarkable success in the second quarter of this year. The company recorded sales of 307.1 billion won and operating profit of 36.2 billion won, marking a 4.5% and 7.8% increase, respectively, compared to […]
Daewoong Acquires Stake in US Partner ‘Privatera’ to Strengthen Global Treatment Business
Daewoong Acquires Stake in US Partner ‘Privatera’ Daewoong Group’s holding company, Daewoong, announced on the 24th that it has obtained 3.46 million shares from its US partner, Privatera Acquisition, for approximately KRW 43.8 billion. This represents 3.4% of Daewoong’s equity capital, bringing its total stake in Privatera to 12.63%. The purpose of this acquisition is […]
Daewoong Pharmaceutical’s Nabota Shows Long-Term Effect on Glabellar Wrinkles in Phase 2 Trial
Daewoong Pharmaceutical Announces Success of High-Dose Clinical Trial for Botulinum Toxin Daewoong Pharmaceutical, led by CEOs Jeon Seung-ho and Lee Chang-jae, has recently announced the completion of a successful high-dose phase 2 clinical trial for their botulinum toxin product, Nabota (known as Jubo in the US). The trial aimed to test the long-term effects of […]
Daewoong Pharmaceutical holds a ‘One Day Master Class’
Daewoong Pharmaceutical announced on the 16th that it was holding a ‘Daewoong Aesthetic One-Day Master Class’ for medical staff in Seoul and other metropolitan areas on the 14th and suggested a solution to chronic pain. [메디칼업저버 손형민 기자] Daewoong Pharmaceutical (CEO Jeon Seung-ho and Lee Chang-jae) announced on the 16th that they are holding a […]
